Results 141 to 150 of about 120,253,457 (190)
Management of donor-specific antibodies in allogeneic hematopoietic cell transplantation: A retrospective single-center case-control study. [PDF]
Harland L +10 more
europepmc +1 more source
Efficacy of extracorporeal immunoadsorption therapy for removal of HBsAg. [PDF]
Wang M, Zhou Q, Wu H, Wang Y.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Removal of antiacetylcholine receptor antibodies by protein-A immunoadsorption in myasthenia gravis
Myasthenia Gravis is an autoimmune disease in which autoantibodies to the acetylcholine receptor interfere with neuromuscular transmission. Plasma exchange is effective in temporarily relieving the symptoms of the disease, but for repeated use the lack ...
E. Berta +7 more
semanticscholar +2 more sources
Goodpasture's Syndrome Treated With Staphylococcal Protein A Immunoadsorption.
Lancet, The, 1985T Lindholm, Ole Simonsen, O Simonsen
exaly +2 more sources
Severe Adverse Effects of Protein A Immunoadsorption
Lancet, The, 1994Bettina Wedi, V Kiefel, H Kroll
exaly +2 more sources
Effects of Protein A Immunoadsorption in Patients With Advanced Chronic Dilated Cardiomyopathy
Journal of Clinical Apheresis, 2009Arnt V Kristen +2 more
exaly +2 more sources
Neuroimmunomodulation, 2021
Background: Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy (GFAP-A) is a recently defined autoimmune inflammatory disease of the central nervous system in which GFAP IgG is present in the cerebrospinal fluid (CSF).
B. Qin +6 more
semanticscholar +1 more source
Background: Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy (GFAP-A) is a recently defined autoimmune inflammatory disease of the central nervous system in which GFAP IgG is present in the cerebrospinal fluid (CSF).
B. Qin +6 more
semanticscholar +1 more source
Protein A immunoadsorption in the treatment of malignant disease.
Circulating immune complexes (CIC) are known to be present in cancer patients and are responsible for much of the cancer-associated immunosuppression. Removal or modulation of these "blocking factors" can reverse the immunosuppression.
G. Messerschmidt +9 more
semanticscholar +2 more sources

